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Background and purpose — Data from the national joint regis-
tries in Australia and England and Wales have revealed inferior 
medium-term survivorship for metal-on-metal (MoM) total hip 
arthroplasty (THA) than for metal-on-polyethylene (MoP) THA. 
Based on data from the Nordic Arthroplasty Register Association 
(NARA), we compared the revision risk of cementless stemmed 
THA with MoM and MoP bearings and we also compared MoM 
THA to each other. 
Patients and methods — We identified 32,678 patients who 
were operated from 2002 through 2010 with cementless stemmed 
THA with either MoM bearings (11,567 patients, 35%) or MoP 
bearings (21,111 patients, 65%). The patients were followed 
until revision, death, emigration, or the end of the study period 
(December 31, 2011), and median follow-up was 3.6 (interquar-
tile range (IQR): 2.4–4.8) years for MoM bearings and 3.4 (IQR: 
2.0–5.8) years for MoP bearings. Multivariable regression in the 
presence of competing risk of death was used to assess the relative 
risk (RR) of revision for any reason (with 95% confidence interval 
(CI)).
Results — The cumulative incidence of revision at 8 years of 
follow-up was 7.0% (CI: 6.0–8.1) for MoM bearings and 5.1% 
(CI: 4.7–5.6) for MoP bearings. At 6 years of follow-up, the RR 
of revision for any reason was 1.5 (CI: 1.3–1.7) for MoM bearings 
compared to MoP bearings. The RR of revision for any reason 
was higher for the ASR (adjusted RR = 6.4, CI: 5.0–8.1), the Con-
serve Plus (adjusted RR = 1.7, CI: 1.1–2.5) and “other” acetabu-
lar components (adjusted RR = 2.4, CI: 1.5–3.9) than for MoP 
THA at 6 years of follow-up. 
Interpretation — At medium-term follow-up, the survivorship 
for cementless stemmed MoM THA was inferior to that for MoP 
THA, and metal-related problems may cause higher revision 
rates for MoM bearings with longer follow-up.  
      
Wear particles from the polyethylene liner in metal-on-poly-
ethylene (MoP) bearings in total hip arthroplasty (THA) are 
associated with osteolysis and aseptic loosening of the implant 
(Jacobs et al. 1994). Surgeons therefore became interested in 
alternatives such as metal-on-metal (MoM) bearings. The 
main justification for using large-diameter-head (LDH) MoM 
bearings in THA was less wear and the hope of lower revision 
rates. However, a lower risk of revision has only been found for 
revision due to dislocation (Kostensalo et al. 2013), whereas 
the total risk of revision has been found to be increased in 
some studies (Smith et al. 2012, Huang et al. 2013). In addi-
tion, LDH MoM was introduced in order to achieve increased 
range of motion and better function (Burroughs et al. 2005, 
Davis et al. 2007), but that has not been shown clinically 
(Penny et al. 2013).
Several concerns about the use of MoM bearings in hip sur-
gery have been voiced in recent years: excessive failure rates 
for certain brands and implant combinations used with MoM 
components have been reported (Langton et al. 2011, Austra-
lian Orthopaedic Association 2013). Some designs are associ-
ated with increased frequency of aseptic loosening (Australian 
Orthopaedic Association 2013), and large head sizes placed 
on conventional stems may cause taper junction failure (Lang-
ton et al. 2012). Exposure to chromium and cobalt may cause 
adverse reactions to metal debris (ARMD) (Langton et al. 
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2010) such as pseudotumors (Pandit et al. 2008) and hyper-
sensivity reactions (Willert et al. 2005) locally in the hip joint. 
Furthermore, metal ions may be genotoxic (Daley et al. 2004).
Only a few population-based studies on MoM bearings in 
stemmed THAs from hip arthroplasty registries have been 
published (Smith et al. 2012, Mokka et al. 2013b, Furnes et 
al. 2014), with only 1 population-based study focusing on 
causes of revision resulting from specific combinations of 
acetabular and femoral components (Mokka et al. 2013b). 
We compared the 6-year revision risk for MoM bearings with 
that for MoP bearings in cementless stemmed THA. In addi-
tion, we studied different designs of stemmed MoM THAs 
and the causes of revision in a population-based follow-
up study using data from the Nordic Arthroplasty Register 
Association (NARA). 
Patients and methods
The background population included approximately 26 mil-
lion inhabitants of Denmark (5.6 million), Norway (5.0 mil-
lion), Sweden (9.5 million), and Finland (5.4 million).
Sources of data
Individual anonymized data  relating to each patient who 
underwent THA as recorded in the arthroplasty registries of 
Denmark, Norway, Sweden, and Finland were merged into 
the NARA database (Herberts et al. 1989, Havelin et al. 2000, 
Lucht 2000, Puolakka et al. 2001). The data provided by each 
registry were transformed according to common definitions of 
minimal datasets required for this study (Havelin et al. 2009). 
Nationally, the primary THA data were linked to potential 
revision data for each patient and de-identified, including 
deletion of the national civil registration number, before inclu-
sion in the NARA database. Data were treated with full confi-
dentiality, and identification of patients at the individual level 
is not possible in this database.
Study population
The study population consisted of patients who received 
stemmed THA with cementless stem and cementless cup with 
either MoM or MoP bearings, and with one of the following 
diagnoses: primary osteoarthritis (OA), femoral head osteo-
necrosis, inflammatory arthritis, or sequelae from childhood 
hip disorder. In MoP bearings, the polyethylene liner could 
be made of either ultra-high-molecular-weight polyethylene 
or (highly) cross-linked polyethylene. 
Since the registration of THA bearings was common for all 
databases in 2002, our study population consisted of patients 
who underwent primary THA surgery between January 1, 2002 
and December 31, 2010 (Figure 1). When a patient received 
bilateral THA operations, only the first was included in the 
study due to the statistical assumption of independent obser-
vations (Ranstam et al. 2011). Of the 2,331 patients excluded 
with unregistered pairs of bearings, 505 of these had a ceramic 
head and 114 had a ceramic liner, eliminating the possibility 
of having MoM or MoP bearings. Thus, 1,712 patients with an 
unambiguous couple of bearings could potentially have either 
MoM or MoP bearings. 
Of the 309,944 primary stemmed THAs in the NARA 
database performed from 2002 through 2010, 32,678 pri-
mary cementless stemmed THAs (11,567 MoM and 21,111 
MoP) with complete information on sex, age group, diagno-
sis, year of surgery, and femoral head size were included in 
the study.
Statistics
Patients entered the study on the date of primary surgery and 
were followed until revision, death, emigration, or the end 
of study period (December 31, 2011), whichever came first. 
Revision was defined as a new surgical intervention includ-
ing partial or complete removal or exchange of the implant. 
Revision for any reason was considered to be the primary end-
point and aseptic loosening, dislocation, and all other causes 
of revision were considered to be secondary endpoints. Time 
since operation was chosen as the underlying time scale in 
the time-to-event analysis, and death was considered to be a 
competing risk.
Figure 1. Inclusion of patients in the study population.
Patients that underwent primary cementless 
total hip arthroplasty between 2002 and 2010 
n = 85,371 
n = 72,920 
n = 65,632 
n = 35,448 
n = 33,117 
n = 32,726 
Study population: n = 32,678 
Missing information om femoral head size (n = 22) 
Missing information on diagnosis (n = 26) 
Dual mobility acetabular systems (n = 391) 
Missing information on bearings (n = 2,331) 
Ceramic-on-Polyethylene bearings (n = 10,499) 
Ceramic-on-Ceramic bearings (n = 5,390) 
Metal-on-Ceramic bearings (n = 1,027) 
Other types of bearings (n = 13,268) 
Diagnosed with hip fracture (n = 4,455) 
"Other" diagnoses (n = 2,833) 
Second THA when bilaterally operated (n = 12,451) 
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For the presentation of demographic data and procedure char-
acteristics, descriptive statistics were used. The chi-square test 
was used to compare proportions, and the 2-sample Wilcoxon 
rank-sum test was used to compare ages and follow-up times 
between groups because of skewness. For ages and follow-up 
times, medians and interquartile ranges (IQRs) are presented. 
Revision rates (per 100 person-years) were assessed for each 
group of bearings or specific components as the number of 
revisions divided by the total risk time. Cumulative incidence 
curves were computed using the Aalen-Johansen estimator to 
allow for competing risk. Competing risk analyses were used, 
as the Kaplan-Meier estimator is known to overestimate revi-
sion rates (Gillam et al. 2010, National Joint Registry for Eng-
land and Wales 2011). The cumulative incidence curves were 
ended when the number of patients at risk was below 50, due 
to the expected statistical uncertainty in the estimates.
Pseudo-values based on the Aalen-Johansen estimator were 
calculated at the prespecified time points 1, 2, 3, 4, 5, and 6 
years. The pseudo-observation is a transformation of the time-
to-event data in which each time-to-event observation is rep-
resented by the amount of information it contains when the 
observation is deleted from the dataset. Once the pseudo-obser-
vations have been computed, a model for relative risk (RR) for 
the uncensored data was applied via a generalized estimating 
equation. In practice, the generalized estimating equation can 
be obtained in a generalized linear model for the pseudo-values 
with normal distribution and robust variance estimation (Klein 
et al. 2007, Parner and Andersen 2010). Adjustments were 
made for sex, age, and diagnosis for primary THA when com-
paring MoM bearings and MoP bearings.
Subanalyses were performed for postoperative follow-up 
at 1 to 6 years. We performed stratified analyses on sex and 
age, on OA as diagnosis, and on different component designs 
focusing on the most prevalent cups and the most prevalent 
pairs of cups and stems. We also performed stratified analy-
ses on component designs within the MoM group, with the 
most frequently used acetabular component and combina-
tion of acetabular and femoral components as reference.  The 
stratified analyses within the MoM group were adjusted for 
sex, age, diagnosis for primary THA, and femoral head size 
(categorized as ≤ 37 mm, 38–39 mm, 40–43 mm, 44–47 mm, 
48–51 mm, and ≥ 52 mm). Furthermore, a stratified analysis 
on femoral head size was performed within the MoM group. 
All analyses were stopped at 6 years of follow-up as one ace-
tabular component (Conserve Plus) had a maximum follow-up 
period of 6 years. When performing stratified analyses, each 
stratum had at least 10 registered revisions.
In August 2010, DePuy Orthopaedics voluntarily recalled 
the Articular Surface Replacement (ASR) acetabular compo-
nent used in both hip resurfacing arthroplasty and THA, due 
to a 5-year revision rate of approximately 12% for the ASR 
Hip Resurfacing System and approximately 13% for the ASR 
XL Acetabular System (DePuy Companies 2013). Thus, after 
exclusion of patients with the ASR acetabular component, 
additional regression analysis as described above was per-
formed to determine the RR of any revision for MoM THA 
compared to MoP THA at 6 years of follow-up, with adjust-
ment for sex, age, and diagnosis for primary THA. Also, strati-
fied analysis on femoral head size was performed after exclu-
sion of ASR patients, comparing risk of any revision at 6 years 
of follow-up within the MoM group.
Any p-value < 0.05 was considered significant, and 95% 
confidence intervals (CIs) were computed. Statistical analyses 
were carried out using Stata statistical software, release 13.1.
Results
Description of the study population
The characteristics of the study population are presented in 
Table 1. Of the whole population, 35% had MoM THAs and 
65% had MoP THAs. The proportion of males who had MoM 
THAs was higher than the proportion who had MoP THAs. 
The median patient ages in the 2 groups were 62 (56–69) years 
for MoM and 62 (56–68) years for MoP (p < 0.001). The most 
common diagnosis for THA was OA accounting for 92% of 
all MoM bearings and 89% of all MoP bearings (p < 0.001). 
In the MoM group, 3% were diagnosed with sequelae from 
childhood hip disorders. The corresponding figure in the MoP 
group was 6% (p < 0.001). Regarding femoral head size, 92% 
of MoM THAs had 38-mm or larger femoral heads, and 97% 
of MoP THAs had head sizes smaller than 38 mm (p < 0.001). 
From 2002 through 2006, 23% received MoM bearings and 
35% received MoP bearings, whereas from 2007 through 2010 
77% received MoM bearings and 65% received MoP bearings 
(p < 0.001). The 3 most frequently used design combinations 
of acetabular and femoral components in the MoM group were 
Recap/Bi-Metric (43%), M2a/Bi-Metric (21%), and Pinnacle/
Corail (8%), and they were Trilogy/Bi-Metric (17%), Trilogy/
CLS Spotorno (13%), and Mallory-Head/Bi-Metric (8%) in 
the MoP group. Most MoM THAs were performed in Finland 
(72%) and Denmark (23%), whereas MoP THAs were mainly 
performed in Denmark (57%) and Sweden (36%) (Table 1). 
The median follow-up was 3.6 (2.4–4.8) years for MoM bear-
ings and 3.4 (2.0–5.8) years for MoP bearings (p < 0.001).
Risk of revision for any reason
During the study period, we registered 1,236 first-time revi-
sions following primary THA (3.8% of 32,678 patients): 4.1% 
for MoM bearings (470 of 11,567 patients) and 3.6% for MoP 
bearings (766 of 21,111 patients), corresponding to revision 
rates of 1.11 (CI: 1.0–1.2) per 100 person-years for MoM 
THA and 0.91 (CI: 0.85–0.97) per 100 person-years for MoP 
THA. The cumulative incidence of any revision was 7.0% (CI: 
6.0–8.1) for MoM and 5.1% (CI: 4.7–5.6) for MoP at 8 years 
of follow-up (Figure 2). The RR of revision for any reason was 
statistically significantly higher for MoM after 5 and 6 years 
of follow-up (Table 2, see Supplementary data).
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Stratified analyses: risk of revision for any reason
Compared to MoP THA, at 6-year follow-up MoM THA had 
a higher risk of revision for any reason in women less than 60 
years of age (1.8, CI: 1.3–2.4) and women who were 60 years 
old or more (1.9, CI: 1.5–2.4), in men less than 60 years old 
(1.4, CI: 1.1–1.9), and in patients who were diagnosed with 
OA of the hip (1.5, CI: 1.3–1.8). The revision risk was similar 
for MoM THA and MoP THA in men who were 60 years old 
or more.  
For different designs of acetabular components in MoM 
THAs at 6-year follow-up, the RR of revision for any reason 
was higher for the ASR cup, for the Conserve Plus cup, and for 
“other” designs of cups than for the cups used in all the MoP 
THAs (Figure 3 and Table 3, see Supplementary data). The 
MoM cup/stem combinations of ASR/Summit, ASR/Corail, 
and “other” had statistically significantly higher RR of revi-
sion for any reason than MoP THAs in general (Figure 4 and 
Table 3, see Supplementary data). When comparing acetabular 
components in the MoM group with the most frequently used 
as reference (Recap), the ASR, Conserve Plus, and “other” 
cups had significantly higher revision risk at 6-year follow-up 
(Table 4, see Supplementary data). In the cementless stemmed 
MoM THAs, the cup and stem combinations of M2a/Bi-
Metric, ASR/Summit, ASR/Corail, and other combinations of 
components had significantly higher RR of revision for any 
reason than the Recap/Bi-Metric combination (Table 4, see 
Supplementary data). 
For Pinnacle, 75% had femoral head sizes smaller than 
38 mm, and 86% of the M2a cups had femoral head sizes of 
38–39 mm. For Recap, ASR, Birmingham, Durom, and Con-
serve Plus acetabular components, the vast majority had femo-
ral head sizes of 44 mm or larger (95%, 93%, 87%, 87%, and 
89% respectively) (Table 5, see Supplementary data). In the 
MoM group and with femoral head size of 38–39 mm as ref-
erence, a significantly higher RR of revision for any reason at 
6 years was found for femoral head sizes between 44 and 47 
mm. Other head sizes did not reach statistical significance in 
similar comparisons (Table 6). 
Causes of revision
The cementless MoM THAs had a higher proportion of revi-
sions due to aseptic loosening (p < 0.001) and “other” causes 
(p = 0.03). We found a lower frequency of revision due to dis-
location for MoM THA than for MoP THA, irrespective of 
femoral head size (p < 0.001). At 6-year follow-up, the RR of 
revision due to dislocation was lower for MoM bearings than 
for MoP bearings (0.27, CI: 0.19–0.39), but the RR of revision 
due to aseptic loosening (5.5, CI: 3.8–7.9) and all other causes 
of revision (1.2, CI: 1.0–1.5) was higher for MoM bearings 
than for MoP bearings (Table 7, see Supplementary data).
For patients with the ASR acetabular component, 10% (75 
of 759 patients) had revision surgery because of aseptic loos-
ening, 1.3% (10 of 759 patients) had revision because of deep 
infection, and 0.9% (7 of 759 patients) had revision because 
of pain.
Exclusion of the ASR acetabular component
After exclusion of 759 patients with the ASR acetabular 
component, the cumulative incidence of revision for MoM 
THA at 8-year follow-up was 5.0% (CI: 4.3–5.8). Compar-
ing MoM THA with MoP THA, the adjusted RR of revision 
for any reason at 6-year follow-up was 1.1 (CI: 0.97–1.3). 
Repeated analysis with different femoral head sizes did not 
show any significant difference in RR of revision for any 
reason at 6-year follow-up for any head size compared to 
38–39 mm (Table 6).
Table 1. Patient- and surgery-related characteristics for the patients 
who received cementless total hip arthroplasty with metal-on-metal 
(mom) bearings or metal-on-polyethylene (moP) bearings. Values 
are numbers of patients and percentages (%) within each group
 MoM MoP
 n = 11,567 n = 21,111 p-value
Sex   < 0.001
 Female  5,227 (45) 10,689 (51) 
 Male  6,340 (55) 10,422 (49) 
Age groups (years)   < 0.001
 < 40  282 (2) 576 (3) 
 40–49  969 (8) 1,768 (8) 
 50–59 3,188 (28) 5,578 (27) 
 60–69  4,712 (41) 8,249 (39) 
 70–79  2,200 (19) 4,007 (19) 
 ≥ 80  216 (2) 933 (4) 
Diagnosis   < 0.001
 Primary OA  10,595 (92) 18,694 (89) 
 Femoral head osteonecrosis 232 (2) 631 (3) 
 Arthritis  404 (3) 427 (2) 
 Childhood hip disorders  336 (3) 1,359 (6) 
Femoral head size (mm)   < 0.001
 ≤ 27  7 (0) 221 (1) 
 28–31 118 (1) 10,374 (49) 
 32–35 117 (1) 5,842 (28) 
 36–37 707 (6) 4,068 (19) 
 38–39 2,317 (20) 17 (0) 
 40–43 679 (6) 403 (2) 
 44–47 2,431 (21) 44 (0) 
 48–51 3,124 (27) 38 (0) 
 ≥ 52  2,067 (18) 104 (1) 
Year of surgery   < 0.001
 2002 17 (0) 484 (2) 
 2003 39 (0) 1,394 (7) 
 2004 109 (1) 1,647 (8) 
 2005 887 (8) 1,867 (9) 
 2006 1,641 (14) 2,097 (10) 
 2007 2,305 (20) 2,385 (11) 
 2008 2,691 (23) 2,837 (13) 
 2009 2,357 (21) 3,661 (17) 
 2010 1,521 (13) 4,739 (23) 
Country   < 0.001
 Denmark 2,636 (23) 12,103 (57) 
 Norway 88 (1) 1,141 (6) 
 Sweden 454 (4) 7,597 (36) 
 Finland 8,389 (72) 270 (1) 
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ite
tsb
ibl
iot
ek
et 
i B
erg
en
] a
t 0
1:3
7 3
0 D
ec
em
be
r 2
01
5 
Acta Orthopaedica 2015; 86 (4): 469–476 473
Discussion
In this population-based study from the NARA database, the 
RR of revision for any reason at 6 years of follow-up was 49% 
higher for MoM THA than for MoP THA, whereas the RR of 
revision for any reason was similar for both after exclusion of 
ASR acetabular components. There was a high risk of revision 
with prosthetic design combinations of ASR/Summit and ASR/
Corail relative to MoP THA. In all patients with MoM THA, we 
found a higher risk of revision for femoral head sizes between 
44 and 47 mm than for a femoral head size of 38–39 mm. 
Risk of revision for any reason
In the Australian Orthopaedic Association National Joint 
Replacement Registry (AOA NJRR), the cumulative percent-
age of revision of MoM THA was 9.6 (CI: 9.2–10.0) at 5 years 
and 15.5 (CI: 14.8–16.2) at 10 years (Australian Orthopaedic 
Association 2013), which is more than the cumulative inci-
dence of revision at 8 years found in our study. The lower 
incidence found by us could be due to differences in the use 
of specific component designs. In the present study, the Recap 
constituted 47% of all acetabular components in the MoM 
Figure 2. Cumulative incidence for any revi-
sion of cementless total hip arthroplasty with 
metal-on-metal (MoM) bearings and metal-
on-polyethylene (MoP) bearings.
Figure 3. Cumulative incidence for revision 
(for any reason) of metal-on-polyethylene 
(MoP) total hip arthroplasty (THA) and spe-
cific designs of cementless acetabular com-
ponents in stemmed THA with metal-on-metal 
bearings.
Figure 4. Cumulative incidence for revision (for 
any reason) of metal-on-polyethylene (MoP) 
total hip arthroplasty (THA) and combinations 
of specific designs of cementless acetabular 
and femoral components in stemmed THA 
with metal-on-metal bearings.
Table 6. median follow-up and revision rate for different sizes of the femoral head used in cementless stemmed total hip arthroplasty (THA) 
with metal-on-metal (mom) bearings. Crude and adjusted relative risk (RR) of revision for any reason with 95% confidence intervals (CIs) 
at 6-year follow-up
   Median Any  Revision rate
 No. follow-up revision Risk time,  per 100 years Crude RR Adjusted RR
 (%) (IQR) (n) years (95% CI) (95% CI) (95% CI)
All MoM THAs
 ≤ 37 949 (8) 3.3 (2.2–4.3) 46 3,313 1.39 (1.04–1.85) 1.48 (0.98–2.25) 1.48 (0.95–2.32)
 38–39 2,317 (20) 4.9 (3.3–6.1) 93 10,673 0.87 (0.71–1.07) 1 (ref.) 1 (ref.)
 40–43 679 (6) 3.0 (2.1–4.3) 20 2,189 0.91 (0.59–1.42) 1.07 (0.65–1.77) 1.14 (0.65–2.02)
 44–47 2,431 (21) 3.4 (2.3–4.5) 128 8,443 1.52 (1.27–1.80) 1.77 (1.27–2.48) 1.68 (1.17–2.40)
 48–51 3,124 (27) 3.3 (2.3–4.5) 108 10,668 1.01 (0.84–1.22) 1.27 (0.90–1.80) 1.38 (0.93–2.04)
 ≥ 52 2,067 (18) 3.2 (2.3–4.4) 75 6,917 1.08 (0.86–1.36) 1.14 (0.79–1.62) 1.33 (0.92–1.93)
MoM THAs after exclusion of patients having the ASR acetabular component
 ≤ 37 938 (9) 3.3 (2.2–4.3) 45 3,257 1.38 (1.03–1.85) 1.38 (0.91–2.08) 1.40 (0.90–2.19)
 38–39 2,314 (21) 4.9 (3.3–6.1) 93 10,661 0.87 (0.71–1.07) 1 (ref.) 1 (ref.)
 40–43 643 (6) 3.0 (2.1–4.2) 15 2,049 0.73 (0.44–1.21) 0.74 (0.44–1.26) 0.75 (0.42–1.32)
 44–47 2,136 (20) 3.4 (2.3–4.4) 83 7,302 1.14 (0.92–1.41) 1.06 (0.76–1.49) 1.00 (0.68–1.48)
 48–51 2,866 (26) 3.3 (2.3–4.4) 75 9,696 0.77 (0.62–0.97) 0.83 (0.58–1.18) 0.90 (0.59–1.39)
 ≥ 52 1,918 (18) 3.2 (2.2–4.3) 59 6,365 0.93 (0.72–1.20) 0.83 (0.58–1.19) 0.97 (0.66–1.43)
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group and the ASR only 7% of them, whereas the ASR cup 
was used far more frequently in Australia. In contrast, the 
Recap cup with the second lowest revision rate at 7 years was 
used to a lesser extent (Australian Orthopaedic Association 
2013). In both the NARA database and the AOA NJRR, the 
ASR cup had the highest cumulative incidence of revision but 
was used with different frequency, which could explain the 
different revision rates in these 2 registries. A study from the 
National Joint Registry of England and Wales (Smith et al. 
2012) excluded the ASR implants from the analysis and found 
an overall 5-year revision rate of 6.2% (CI: 5.8–6.6) for MoM 
THA, which was higher than the 8-year cumulative revision 
rate found in our study after exclusion of the ASR implant. 
This could also be caused by differences in use of certain 
component designs and implant combinations, and also differ-
ences in follow-up and surgical technique.
Stratified analyses: risk of revision for any reason
We found that the cumulative incidence of revision of the 
ASR acetabular component increased to more than 25% at 
5.8 years. The ASR cup had similar cumulative incidence of 
revision in the AOA NJRR, and Langton et al. (2011) found a 
6-year failure rate of 48.8% for the ASR cup used with a con-
ventional stem. In a recent study, the cumulative 7-year sur-
vivorship was 38% (CI: 33–44) for MoM THA with the ASR 
cup with femoral head sizes smaller than 50 mm. The most 
common cause of revision was ARMD, accounting for 86% of 
revisions, and use of the Corail stem had an increased risk of 
ARMD (Reito et al. 2013). Although we have no information 
of the presence of ARMD in our study, patients with the ASR/
Summit combination had a much higher cumulative incidence 
of revision than patients with the ASR/Corail combination, 
which may be explained by the shorter follow-up for ASR/
Corail. In the present study, ASR components were mainly 
revised due to aseptic loosening.
The acetabular component with the best survivorship in 
our study was the Recap cup, with a cumulative incidence 
of revision of 3.4% (CI: 2.8–4.0) at 6-year follow-up. This 
is slightly better than reported in Australia, where the Recap 
acetabular component had the lowest cumulative incidence 
of revision (6.3%, CI: 4.4–8.9) at 7 years among monobloc 
cups (Australian Orthopaedic Association 2013). In a recent 
study with a small series of Recap/M2a-magnum LDH MoM 
THAs including 80 hips with a mean follow-up of 6 years, 
11 hips were considered to have definite ARMD, and revi-
sion had been performed in 3 of these cases (Mokka et al. 
2013a). Another 32 hips were considered to have probable or 
possible ARMD. This indicates a high prevalence of ARMD 
in patients with the Recap cup after medium-term follow-up, 
with the possible consequence of increasing revision rates due 
to metal-related pathology with longer follow-up.
The Pinnacle acetabular component was the only non-
monobloc cup analyzed separately when we performed strati-
fied analyses. The cumulative incidence of revision of the Pin-
nacle cup of 5.1% (CI: 2.9–8.2) found in our study at 5 years 
of follow-up was similar to that found in Australia where the 
5-year revision risk was 3.9% (CI: 2.2–7.0) for Pinnacle/S-
Rom and 4.6% (CI: 3.6–5.8) for Pinnacle/Articul-Eze (Aus-
tralian Orthopaedic Association 2013). In England and Wales, 
the 5-year revision rate following Pinnacle/Corail cement-
less THA with MoM bearings was 4.2% (99% CI: 2.3–6.0) 
(Jameson et al. 2013). The adjusted hazard rate of revision 
for this implant combination was 1.9 (99% CI: 1.4–2.7) when 
compared to MoP bearings (Jameson et al. 2013). In the pres-
ent study, the RR of revision of the Pinnacle/Corail MoM 
THA was similar to that of MoP THA.
Femoral head size is a major risk factor for revision of MoM 
THA, with increasing revision rates with increasing head size 
(Graves et al. 2011, Smith et al. 2012, Australian Orthopaedic 
Association 2013). When we compared MoM THA with dif-
ferent femoral head sizes to MoM THA with 38- to 39-mm 
heads, the RR of revision for any revision was statistically 
significantly higher for head sizes of 44–47 mm. This femo-
ral head size was the most prevalent with the ASR cup. After 
exclusion of patients with the ASR implant, only femoral head 
sizes smaller than 38 mm had higher RR of revision than head 
sizes of 38–39 mm, and the larger head sizes had similar or 
even lower RR of revision when compared to 38–39 mm—
although the differences were not significant. As the Pinnacle 
cup had the majority of the smallest head sizes and revision 
risk changed when the ASR implant was excluded, it appears 
that component design is an important factor when interpret-
ing revision risk with different femoral head sizes in MoM 
THA.
Causes of revision
The most common cause of revision of MoM THA at 8 years 
of follow-up in Australia was metal-related pathology, fol-
lowed by aseptic loosening and infection for femoral head 
sizes larger than 32 mm (Australian Orthopaedic Associa-
tion 2013). It is not possible to identify revisions performed 
for “metal-related pathology” in the NARA database, but it 
is possible that some of these MoM-bearing complications 
are registered as revisions performed for “other” reasons. 
In the study from the National Joint Registry of England 
and Wales, the most common reason for revision of cement-
less stemmed MoM THA was aseptic loosening (Smith et 
al. 2012). In our study, the frequency of revision due to 
aseptic loosening and “other” causes was higher for MoM 
THA than for MoP THA. The frequency and RR of revision 
due to dislocation was, however, lower for MoM bearings 
than for MoP bearings. In a recent study from the Finnish 
Arthroplasty Register, the RR of revision due to dislocation 
was 0.09 (CI: 0.05–0.17) for head sizes larger than 36 mm 
compared to 28 mm (Kostensalo et al. 2013). Thus, the low 
risk of revision of MoM THA due to dislocation might be 
explained by the fact that MoM THAs in that study mainly 
had head sizes larger than 37 mm.
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Methodological considerations
Some strengths of the present study were the population-based 
design with prospective collection of data and a large sample 
size. The complete follow-up of the study population limited 
possible selection bias. The study also had several limitations 
that should be considered when interpreting the results. The 
exclusion of 1,712 patients—who could have had either MoM 
or MoP bearings but were registered without unambiguous 
information on bearings—may have led to information bias. 
We analyzed the 2 worst-case scenarios by assuming that all 
1,712 THAs had received either MoM or MoP bearings. Inclu-
sion of all 1,712 THAs in the MoM group gave an adjusted 
RR of revision for any reason at 6-year follow-up of 1.4 (CI: 
1.3–1.6) for MoM THA vs. MoP THA. Inclusion of all 1,712 
THAs in the MoP group gave an adjusted RR of revision for 
any reason at 6-year follow-up of 1.4 (CI: 1.3–1.6) for MoM 
THA vs. MoP THA. Thus, in both cases, the risk of revision 
would have been higher for MoM bearings than for MoP bear-
ings, as was found after exclusion of the patients. The exclu-
sion of the 48 patients with unregistered information on diag-
nosis or femoral head size can be assumed to have had no 
influence on the results of the study, due to the large study 
population.
The distribution of THAs with MoM and MoP bearings 
varied between countries. Finland and Denmark contributed 
the majority of MoM THAs, and Sweden and Denmark con-
tributed the majority of MoP THAs. From previous studies 
(Havelin et al. 2009, Makela et al. 2014), we know that there is 
variation in outcome in terms of implant survival between the 
Nordic countries, which may in part be caused by differences 
in demography and implant selection. Most of the implants 
included in this study were, however, used in several countries. 
We also adjusted for sex, age, and diagnosis, and performed 
subanalyses on specific implants. Even so, any differences 
between countries caused by factors that not were captured 
in the NARA database could have influenced our results, but 
it was not our aim to evaluate differences between countries. 
Since the healthcare systems, patient populations, and treat-
ment traditions in the Nordic countries are rather homogenous, 
we believe that any influence of skewed inclusion of patients 
from the countries involved in this study would be small.
Although we adjusted for several confounders, there is still 
the possibility of unidentified confounding. The regression 
model used to compare MoM THA with MoP THA did not 
include adjustment for femoral head size, despite the fact that 
it is a well-documented risk factor (Smith et al. 2012, Austra-
lian Orthopaedic Association 2013): As 92% of MoM THAs 
had femoral head sizes greater than 37 mm and 97% of MoP 
THAs had head sizes smaller than 38 mm, femoral head size 
could be considered to be a proxy for the bearings used in 
THA, and it was therefore not adjusted for in the model. Fur-
thermore, the NARA database does not contain any informa-
tion on potential confounders such as blood concentrations of 
chromium and cobalt, comorbidity, height, weight, BMI, or 
physical activity before or after surgery. In addition, we had no 
information from any radiographic examinations or magnetic 
resonance imaging, either for revised or unrevised hips, and 
we could not account for silent, unrevised metal reactions.
Another limitation was the short follow-up, resulting in 
a high proportion of revisions due to surgical and technical 
errors. Registry studies are unable to detect silent, unrevised 
metal reactions, and with longer follow-up, a change in causes 
of revision may result in an increased proportion of revisions 
related to mechanical wear and ARMD. Also, the number of 
revisions was low, and the sensitivity to random effects of 
single revision cases could thereby be increased when per-
forming stratified analyses. Furthermore, the revision causes 
registered have not been validated in the national registries 
contributing to the NARA database, and revisions due to 
“metal-related pathology” such as ARMD have not been reg-
istered.
Conclusion
We found a higher RR of revision for any reason at 6-year 
follow-up for MoM THA than for MoP THA, but after exclu-
sion of patients with the ASR acetabular component, the risk 
of revision was similar between the 2 groups of bearings. 
At 6-year follow-up, there was a much higher risk of revi-
sion with prosthetic design combinations of ASR/Summit and 
ASR/Corail than for MoP THA, whereas the risk of revision 
was similar for the Recap/Bi-Metric combination and for MoP 
THA. In MoM THA, we found a higher risk of revision for 
femoral head sizes between 44 and 47 mm than for 38–39 
mm. After exclusion of patients with the ASR acetabular com-
ponent, the risk of revision was similar for different femoral 
head sizes in MoM THA. 
We recommend that stemmed LDH MoM bearings should 
not be used until further studies with longer follow-up are per-
formed to identify the risk of complications. 
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